Hyper-IgM Immunodeficiency Syndrome
A rare inherited immunodeficiency syndrome characterized by normal or elevated serum IMMUNOGLOBULIN M levels with absence of IMMUNOGLOBULIN G; IMMUNOGLOBULIN A; and IMMUNOGLOBULIN E. It results in a profound susceptibility to BACTERIAL INFECTIONS and an increased susceptibility to OPPORTUNISTIC INFECTIONS. Several subtypes of hyper-IgM immunodeficiency syndrome exist depending upon the location of genetic mutation.
Subtype terms (1)
More specific conditions that are subtypes of Hyper-IgM Immunodeficiency Syndrome in the MeSH hierarchy.
- Hyper-IgM Immunodeficiency Syndrome, Type 1
9 drugs approved
Drugs by status
Phase 4 trials (1)
Organizations
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (1)
Organization Involved with Other Experimental Indications (1)